Dr. Afrasiabi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2571 W La Palma Ave
Anaheim, CA 92801Phone+1 714-827-9797Fax+1 714-827-5377
Summary
- Dr. Kambiz Afrasiabi, based in Anaheim, CA, specializes in Oncology. He completed his residency in Internal Medicine at University of Southern California/LAC+USC Medical Center and his fellowship in Medical Oncology at National Institutes of Health Clinical Center. Moreover, he graduated from Shiraz University of Medical Sciences in 1983. Dr. Afrasiabi has made significant contributions to the field of oncology with numerous publications, the most cited being a 2010 study on Paneth and goblet cell homeostasis. He has been recognized with the Meaningful Use Stage 1 Certification from Centers for Medicare & Medicaid Services.
Education & Training
National Institutes of Health Clinical CenterFellowship, Medical Oncology, 1991 - 1993
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1989 - 1992
Shiraz University of Medical SciencesClass of 1983
Certifications & Licensure
CA State Medical License 1990 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 4 citationsExploiting Cancer’s Tactics to Make Cancer a Manageable Chronic DiseaseKambiz Afrasiabi, Mark E. Linskey, Yi-Hong Zhou
Cancers. 2020-06-22 - 4 citationsDual antivascular function of human fibulin‐3 variant, a potential new drug discovery strategy for glioblastomaChao Ke, Jun‐ran Luo, Zi‐wen Cen, Yanyan Li, Hai-Ping Cai
Cancer Science. 2020-03-01 - 9 citationsHuman fibulin-3 protein variant expresses anti-cancer effects in the malignant glioma extracellular compartment in intracranial xenograft models.Yanyan Li, Yuan Hu, Chuanjin Liu, Qingyue Wang, Xiaoxiao Han
Oncotarget. 2017-11-09
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
